Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Penn Pharma appoints Jerome Detreille senior director

This article was originally published in Scrip

Executive Summary

Specialist provider of pharmaceutical development and manufacturing services Penn Pharma has named Jerome Detreille to its executive team as senior director of new business development. Penn recently invested £14 million in a new South Wales, UK facility, and Mr Detreille's role will be integral to the success of the 15,000 sq ft development and commercial manufacturing unit which will open in January 2013. He joins Penn from Catalent Pharma Solutions where he headed up a European sales and business development team.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC017029

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel